Brief: China Biotech Services Sees Net Profit Of Not Less Than HK$130 Mln For Q3 2020
27/10/2020 14:12
Oct 27 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* EXPECTED TO RECORD A NET PROFIT OF NOT LESS THAN HK$130
MILLION
FOR 2020 Q3
* EXPECTED TURNAROUND DUE TO INCREASE IN DEMAND FOR COVID-19
TESTING SERVICES
Source text for Eikon: ID:nHKS2qNkqD
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)